共同药业
(300966)
| 流通市值：17.19亿 | | | 总市值：25.95亿 |
| 流通股本：7636.82万 | | | 总股本：1.15亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 94,657,088.95 | 133,827,483.67 | 157,140,791.92 | 141,181,205.23 |
| 结算备付金 | - | 0 | - | - |
| 拆出资金 | - | 0 | - | - |
| 交易性金融资产 | 1,010.73 | 1,010.7 | 1,010.63 | 1,010.63 |
| 衍生金融资产 | - | 0 | - | - |
| 应收票据及应收账款 | 187,383,225.81 | 257,875,528.31 | 234,723,715.07 | 204,637,654.13 |
| 其中：应收票据 | 18,806,936.84 | 18,481,550.85 | 22,515,024.53 | 15,969,258.05 |
| 应收账款 | 168,576,288.97 | 239,393,977.46 | 212,208,690.54 | 188,668,396.08 |
| 应收款项融资 | 9,517,056.35 | 4,827,537.43 | 6,061,995.64 | 9,623,992.21 |
| 预付款项 | 13,522,837.68 | 4,653,629.39 | 17,908,414.1 | 10,721,612.3 |
| 应收保费 | - | 0 | - | - |
| 应收分保账款 | - | 0 | - | - |
| 应收分保合同准备金 | - | 0 | - | - |
| 其他应收款合计 | 2,587,664.75 | 2,427,007.97 | 3,674,702.79 | 2,052,867.78 |
| 其中:应收利息 | - | 0 | - | - |
| 应收股利 | - | 0 | - | - |
| 买入返售金融资产 | - | 0 | - | - |
| 存货 | 460,119,764.59 | 440,055,287.92 | 433,172,804.78 | 384,797,242.09 |
| 合同资产 | - | 0 | - | - |
| 一年内到期的非流动资产 | - | 0 | - | - |
| 其他流动资产 | 11,897,799.31 | 10,913,227.35 | 19,741,864.32 | 16,981,792.75 |
| 流动资产合计 | 779,686,448.17 | 854,580,712.74 | 872,425,299.25 | 769,997,377.12 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | - | - |
| 债权投资 | - | 0 | - | - |
| 其他债权投资 | - | 0 | - | - |
| 长期应收款 | - | 0 | - | - |
| 长期股权投资 | 48,300,809.91 | 48,332,445.18 | 48,320,488.02 | 48,268,996.23 |
| 其他权益工具投资 | - | 0 | - | - |
| 其他非流动金融资产 | - | 0 | - | - |
| 投资性房地产 | 17,542,023.41 | 17,699,533.22 | 17,857,043.03 | 18,014,552.84 |
| 固定资产 | 1,616,726,694.37 | 1,136,696,153.48 | 1,130,257,222.26 | 1,154,486,627.36 |
| 在建工程 | 273,908,908.03 | 761,804,636.83 | 730,989,301.94 | 694,413,010.74 |
| 生产性生物资产 | - | 0 | - | - |
| 油气资产 | - | 0 | - | - |
| 使用权资产 | 28,350.61 | 42,525.94 | 56,701.27 | 70,876.6 |
| 无形资产 | 49,045,247.12 | 49,323,853.4 | 49,602,459.68 | 49,881,065.96 |
| 开发支出 | - | 0 | - | - |
| 商誉 | - | 0 | - | - |
| 长期待摊费用 | 7,143,618.63 | 7,970,503.32 | 8,804,934.48 | 9,618,102.36 |
| 递延所得税资产 | 55,183,260.26 | 46,903,061.78 | 40,913,423.56 | 37,290,872.15 |
| 其他非流动资产 | 9,197,384.89 | 11,821,104.14 | 14,325,689.35 | 7,838,847.5 |
| 非流动资产合计 | 2,077,076,297.23 | 2,080,593,817.29 | 2,041,127,263.59 | 2,019,882,951.74 |
| 资产总计 | 2,856,762,745.4 | 2,935,174,530.03 | 2,913,552,562.84 | 2,789,880,328.86 |
| 流动负债: | | | | |
| 短期借款 | 213,246,602.09 | 222,153,151.38 | 291,238,917.77 | 294,303,069.17 |
| 向中央银行借款 | - | 0 | - | - |
| 吸收存款及同业存放 | - | 0 | - | - |
| 拆入资金 | - | 0 | - | - |
| 交易性金融负债 | - | 0 | - | - |
| 衍生金融负债 | - | 0 | - | - |
| 应付票据及应付账款 | 459,801,803.68 | 524,545,403.54 | 465,690,482.39 | 459,913,423.7 |
| 其中：应付票据 | 35,000,000 | 77,066,120 | 57,464,804.4 | 37,117,956 |
| 应付账款 | 424,801,803.68 | 447,479,283.54 | 408,225,677.99 | 422,795,467.7 |
| 预收款项 | 189,064.25 | 329,845.26 | 472,660.55 | 47,266.05 |
| 合同负债 | 222,310.03 | 605,760.17 | 2,104,842.75 | 1,226,484.65 |
| 卖出回购金融资产款 | - | 0 | - | - |
| 应付手续费及佣金 | - | 0 | - | - |
| 应付职工薪酬 | 6,378,941.65 | 5,551,980.57 | 6,368,448.76 | 9,514,285.4 |
| 应交税费 | 893,129.56 | 354,686.32 | 401,178.93 | 2,844,802.3 |
| 其他应付款合计 | 1,060,050.05 | 988,271.02 | 837,504.88 | 899,641.66 |
| 其中:应付利息 | - | 0 | - | - |
| 应付股利 | - | 0 | - | - |
| 应付分保账款 | - | 0 | - | - |
| 保险合同准备金 | - | 0 | - | - |
| 代理买卖证券款 | - | 0 | - | - |
| 代理承销证券款 | - | 0 | - | - |
| 一年内到期的非流动负债 | 63,020,076.12 | 39,152,910.81 | 28,454,955.23 | 24,609,710.86 |
| 其他流动负债 | 18,028,779.85 | 28,062,560.21 | 31,756,083.39 | 14,328,360.44 |
| 流动负债合计 | 762,840,757.28 | 821,744,569.28 | 827,325,074.65 | 807,687,044.23 |
| 非流动负债: | | | | |
| 长期借款 | 645,810,434.51 | 625,098,254.73 | 586,151,083.35 | 484,919,646.66 |
| 应付债券 | 346,698,594.49 | 340,325,879.53 | 333,989,211.11 | 327,722,176.41 |
| 优先股 | - | 0 | - | - |
| 永续债 | - | 0 | - | - |
| 租赁负债 | - | 0 | - | - |
| 长期应付款 | - | 0 | - | - |
| 长期应付职工薪酬 | - | 0 | - | - |
| 预计负债 | - | 4,333,250.51 | 4,648,020.47 | 4,648,020.47 |
| 递延收益 | 142,763,362.78 | 146,177,677.55 | 149,362,080.36 | 150,250,753.02 |
| 递延所得税负债 | 744,076.15 | 173,506.38 | 12,760.97 | 10,633.08 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债合计 | 1,136,016,467.93 | 1,116,108,568.7 | 1,074,163,156.26 | 967,551,229.64 |
| 负债合计 | 1,898,857,225.21 | 1,937,853,137.98 | 1,901,488,230.91 | 1,775,238,273.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 115,281,077 | 115,279,416 | 115,279,416 | 115,279,416 |
| 其他权益工具 | 96,478,233.81 | 96,489,947.36 | 96,489,947.36 | 96,489,947.36 |
| 资本公积 | 411,074,051.09 | 410,963,755.31 | 410,706,015.42 | 410,599,708.03 |
| 减:库存股 | 19,770,502.95 | 3,030,264.52 | 1,921,250.12 | - |
| 其他综合收益 | - | 0 | - | - |
| 专项储备 | - | 0 | - | - |
| 盈余公积 | 9,953,911.25 | 9,953,911.25 | 9,953,911.25 | 9,953,911.25 |
| 一般风险准备 | - | 0 | - | - |
| 未分配利润 | 258,379,818.62 | 279,662,169.68 | 291,896,774.85 | 290,814,696.93 |
| 归属于母公司股东权益合计 | 871,396,588.82 | 909,318,935.08 | 922,404,814.76 | 923,137,679.57 |
| 少数股东权益 | 86,508,931.37 | 88,002,456.97 | 89,659,517.17 | 91,504,375.42 |
| 股东权益合计 | 957,905,520.19 | 997,321,392.05 | 1,012,064,331.93 | 1,014,642,054.99 |
| 负债和股东权益合计 | 2,856,762,745.4 | 2,935,174,530.03 | 2,913,552,562.84 | 2,789,880,328.86 |
| 公告日期 | 2025-10-28 | 2025-08-29 | 2025-04-29 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |